NKTX•benzinga•
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?
Summary
Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 27, 2025 by benzinga